Ferran Nadeu

4.5k total citations
52 papers, 925 citations indexed

About

Ferran Nadeu is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Ferran Nadeu has authored 52 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pathology and Forensic Medicine, 27 papers in Genetics and 21 papers in Oncology. Recurrent topics in Ferran Nadeu's work include Lymphoma Diagnosis and Treatment (30 papers), Chronic Lymphocytic Leukemia Research (27 papers) and Viral-associated cancers and disorders (13 papers). Ferran Nadeu is often cited by papers focused on Lymphoma Diagnosis and Treatment (30 papers), Chronic Lymphocytic Leukemia Research (27 papers) and Viral-associated cancers and disorders (13 papers). Ferran Nadeu collaborates with scholars based in Spain, United States and United Kingdom. Ferran Nadeu's co-authors include Elı́as Campo, Julio Delgado, Xosé S. Puente, Dolors Colomer, Blanca González‐Farré, Ander Díaz‐Navarro, Itziar Salaverría, Carlos López-Otı́n, Neus Villamor and Armando López‐Guillermo and has published in prestigious journals such as Nature, Nature Communications and Blood.

In The Last Decade

Ferran Nadeu

50 papers receiving 915 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ferran Nadeu Spain 17 485 352 348 332 185 52 925
Daniel J. Hodson United Kingdom 18 513 1.1× 290 0.8× 635 1.8× 404 1.2× 323 1.7× 45 1.4k
Alba Navarro Spain 21 686 1.4× 528 1.5× 409 1.2× 361 1.1× 178 1.0× 33 1.1k
Merrill Boyle Canada 14 768 1.6× 374 1.1× 677 1.9× 519 1.6× 284 1.5× 37 1.4k
Mattias Berglund Sweden 19 746 1.5× 317 0.9× 430 1.2× 490 1.5× 198 1.1× 44 1.2k
James Q. Wang Australia 9 579 1.2× 273 0.8× 222 0.6× 392 1.2× 149 0.8× 12 904
Marco Fangazio Italy 10 483 1.0× 346 1.0× 219 0.6× 273 0.8× 75 0.4× 20 727
Cecilia Carpio Spain 15 270 0.6× 200 0.6× 214 0.6× 388 1.2× 79 0.4× 55 774
Jean‐Michel Picquenot France 17 508 1.0× 178 0.5× 215 0.6× 429 1.3× 239 1.3× 48 908
Fong Chun Chan Canada 15 650 1.3× 209 0.6× 289 0.8× 552 1.7× 191 1.0× 30 1.1k
Olga Plotnikova United States 7 487 1.0× 202 0.6× 349 1.0× 323 1.0× 205 1.1× 9 853

Countries citing papers authored by Ferran Nadeu

Since Specialization
Citations

This map shows the geographic impact of Ferran Nadeu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferran Nadeu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferran Nadeu more than expected).

Fields of papers citing papers by Ferran Nadeu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ferran Nadeu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferran Nadeu. The network helps show where Ferran Nadeu may publish in the future.

Co-authorship network of co-authors of Ferran Nadeu

This figure shows the co-authorship network connecting the top 25 collaborators of Ferran Nadeu. A scholar is included among the top collaborators of Ferran Nadeu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ferran Nadeu. Ferran Nadeu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duran‐Ferrer, Martí, Diego Mallo, Ferran Nadeu, et al.. (2025). Fluctuating DNA methylation tracks cancer evolution at clinical scale. Nature. 645(8081). 764–773. 2 indexed citations
2.
Chapiro, Élise, Ferran Nadeu, Thorsten Zenz, et al.. (2024). Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes. Blood Advances. 8(24). 6297–6307. 1 indexed citations
3.
Chapaprieta, Vicente, Núria Russiñol, Ferran Nadeu, et al.. (2023). CHROMATIN ACTIVATION PROFILING OF STEREOTYPED CHRONIC LYMPHOCYTIC LEUKEMIAS REVEALS A SUBSET #8 SPECIFIC SIGNATURE. Blood. 141(24). 2955–2960. 2 indexed citations
4.
Abrisqueta, Pau, Ferran Nadeu, Gloria Iacoboni, et al.. (2023). From genetics to therapy: Unraveling the complexities of Richter transformation in chronic lymphocytic leukemia. Cancer Treatment Reviews. 120. 102619–102619. 4 indexed citations
5.
Valero, Juan García, Ferran Nadeu, Renaud Morin, et al.. (2023). A novel patient-derived 3D model recapitulates mantle cell lymphoma lymph node signaling, immune profile and in vivo ibrutinib responses. Leukemia. 37(6). 1311–1323. 17 indexed citations
6.
Nadeu, Ferran, Silvia Martín, Pablo Mozas, et al.. (2023). MALAT1 expression is associated with aggressive behavior in indolent B-cell neoplasms. Scientific Reports. 13(1). 16839–16839. 5 indexed citations
7.
Arenas, Fabián, Romina Royo, Irene López‐Oreja, et al.. (2023). Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation. Leukemia. 38(3). 557–569. 8 indexed citations
8.
Díaz‐Navarro, Ander, et al.. (2022). RFcaller: a machine learning approach combined with read-level features to detect somatic mutations. NAR Genomics and Bioinformatics. 5(2). lqad056–lqad056. 1 indexed citations
9.
Díaz‐Navarro, Ander, Ferran Nadeu, Ana S. Pitiot, et al.. (2022). PanCancer analysis of somatic mutations in repetitive regions reveals recurrent mutations in snRNA U2. npj Genomic Medicine. 7(1). 19–19. 7 indexed citations
10.
Balsas, Patricia, Ferran Nadeu, Álvaro Eguileor, et al.. (2022). Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma. Leukemia. 37(2). 408–421. 4 indexed citations
11.
Balsas, Patricia, Luis Veloza, Guillem Clot, et al.. (2021). SOX11, CD70, and Treg cells configure the tumor immune microenvironment of aggressive mantle cell lymphoma. Blood. 138(22). 2202–2215. 32 indexed citations
12.
Rustad, Even H, Ferran Nadeu, Nicos Angelopoulos, et al.. (2021). mmsig: a fitting approach to accurately identify somatic mutational signatures in hematological malignancies. Communications Biology. 4(1). 424–424. 17 indexed citations
13.
Demajo, Santiago, Guillem Clot, Giancarlo Castellano, et al.. (2020). A Cyclin D1–Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell Lymphoma. Clinical Cancer Research. 27(1). 213–225. 10 indexed citations
14.
Mozas, Pablo, Marc Sorigué, Alfredo Rivas‐Delgado, et al.. (2020). The interval between frontline treatment and the second relapse (PFS2) predicts survival from the second relapse in follicular lymphoma patients. European Journal Of Haematology. 106(3). 428–432. 1 indexed citations
15.
Gassner, Franz Josef, Nadja Zaborsky, Ilana Buchumenski, et al.. (2020). RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia. Leukemia. 35(4). 1053–1063. 22 indexed citations
16.
Delgado, Julio, Ferran Nadeu, Dolors Colomer, & Elı́as Campo. (2020). Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies. Haematologica. 105(9). 2205–2217. 58 indexed citations
17.
Mozas, Pablo, Ferran Nadeu, Alfredo Rivas‐Delgado, et al.. (2020). Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience. Blood Cancer Journal. 10(3). 31–31. 25 indexed citations
18.
Nadeu, Ferran, Romina Royo, Francesco Maura, et al.. (2020). Minimal spatial heterogeneity in chronic lymphocytic leukemia at diagnosis. Leukemia. 34(7). 1929–1933. 1 indexed citations
19.
Maura, Francesco, Andrea Degasperi, Ferran Nadeu, et al.. (2019). A practical guide for mutational signature analysis in hematological malignancies. Nature Communications. 10(1). 2969–2969. 99 indexed citations
20.
Shuai, Shimin, Hiromichi Suzuki, Ander Díaz‐Navarro, et al.. (2019). The U1 spliceosomal RNA is recurrently mutated in multiple cancers. Nature. 574(7780). 712–716. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel J. Hodson Breakdown of academic impact, for papers by Alba Navarro Breakdown of academic impact, for papers by Merrill Boyle Breakdown of academic impact, for papers by Mattias Berglund Breakdown of academic impact, for papers by James Q. Wang Breakdown of academic impact, for papers by Marco Fangazio Breakdown of academic impact, for papers by Cecilia Carpio Breakdown of academic impact, for papers by Jean‐Michel Picquenot Breakdown of academic impact, for papers by Fong Chun Chan Breakdown of academic impact, for papers by Olga Plotnikova
Rankless by CCL
2026